EUCTR2004-000609-23-IT进行中（未招募）不适用
A randomized, double blind, placebo controlled, parallel-group study to determine the effect of BXL-628 in post-menopausal women with Overactive Bladder (OAB)
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- BIOXELL SPA
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Evaluation of probiotic Akkermansia Muciniphila strain in patients with IBS.CTRI/2024/03/064023Vidya Herbs Pvt LTD
进行中（未招募）
1 期
Investigate the safety and efficacy of study drug ABX464 compared with placebo in patients with moderate to severe ulcerative colitis who have failed to other treatments.Moderate to Severe Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-003558-26-DEABIVAX232
进行中（未招募）
1 期
A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors - Permanent Atrial fibriLLAtion outcome Study using Dronedarone on top of standard therapy (PALLAS)MedDRA version: 14.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersAtrial FibrillationEUCTR2010-019791-73-NLSanofi-aventis recherche & développement10,800
已完成
不适用
This is single center study wherein the safety and efficacy of DigeZyme® in comparison to placebo will be studied in patients with non ulcer functional dyspepsia and delayed onset muscle soreness (DOMS)CTRI/2015/09/006148Sami labs Limited60
Unknown
3 期
Effect of dronedarone on Cardiac patients with permenant atrial fibrilation (i.e.irregular heart beat)CTRI/2011/06/001844SanofiSynthelabo India Limited10,800